DLG4 and bronchopulmonary dysplasia: Meanwhile, ROS treatment also improved the expression of PSD95 in the CA1 region of BPD + NS mice at P14 (Figure 6E,F; F(2,21) = 8.561, p = 0.0019 for treatment; p = 0.0009 for BPD + NS vs. CON and p = 0.0337 for BPD + NS vs. BPD + ROS in Figure 6F) and P70 (Figure 6G,H; F(2,25) = 15.39, p < 0.0001 for treatment; p < 0.0001 for BPD + NS vs. CON and p = 0.0480 for BPD + NS vs. BPD + ROS in Figure 6H).